- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kalvista Pharmaceuticals Inc (KALV)"Kalvista Pharmaceuticals Inc stock price live, this page displays NASDAQ KALV stock exchange data. View the KALV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kalvista Pharmaceuticals Inc real time stock price chart below.
What Is the Kalvista Pharmaceuticals Inc Stock Price Today?
The Kalvista Pharmaceuticals Inc stock price today is 8.74.
What Is the Stock Symbol for Kalvista Pharmaceuticals Inc?
The stock symbol for Kalvista Pharmaceuticals Inc is ""KALV.""
What Stock Exchange Does Kalvista Pharmaceuticals Inc Trade On?
Kalvista Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Kalvista Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Kalvista Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KALV quote. (ISIN: US4834971032)"
What Is the Kalvista Pharmaceuticals Inc Stock Price Today?
The Kalvista Pharmaceuticals Inc stock price today is 8.74.
What Is the Stock Symbol for Kalvista Pharmaceuticals Inc?
The stock symbol for Kalvista Pharmaceuticals Inc is ""KALV.""
What Stock Exchange Does Kalvista Pharmaceuticals Inc Trade On?
Kalvista Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Kalvista Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Kalvista Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KALV quote. (ISIN: US4834971032)"
NASDAQ
Currency in USD
8.74
-0.35(-3.80%)
Closed
After Hours
8.740.00(0.00%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.50
9.15
52 wk Range
8.50
16.88
KALV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.509.15
52 wk Range
8.5016.88
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KALV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
28.50
Upside
+226.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- KalVista shares hold buy rating on HAE drug outlook
- Investing.com
- KalVista shares hold buy rating on HAE drug outlook
- Investing.com
Kalvista Pharmaceuticals Inc Company Profile
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company’s product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. The company is headquartered in Cambridge, Massachusetts.
Compare KALV to Peers and Sector
Metrics to compare | KALV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKALVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.8x | −4.0x | −0.6x | |
PEG Ratio | 0.15 | 0.15 | 0.00 | |
Price/Book | 3.2x | 2.7x | 2.6x | |
Price / LTM Sales | - | 20.4x | 3.2x | |
Upside (Analyst Target) | 235.5% | 204.8% | 40.6% | |
Fair Value Upside | Unlock | 15.1% | 7.1% | Unlock |
Analysts' Recommendations
7 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 28.50
(+226.09% Upside)
People Also Watch
FAQ
What Is the Kalvista Pharma (KALV) Stock Price Today?
The Kalvista Pharma stock price today is 8.74
What Stock Exchange Does Kalvista Pharma Trade On?
Kalvista Pharma is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Kalvista Pharma?
The stock symbol for Kalvista Pharma is "KALV."
What Is the Kalvista Pharma Market Cap?
As of today, Kalvista Pharma market cap is 433.40M.
What is Kalvista Pharma Earnings Per Share?
The Kalvista Pharma EPS is -3.66.
What Is the Next Kalvista Pharma Earnings Date?
Kalvista Pharma will release its next earnings report on Mar 11, 2025.
From a Technical Analysis Perspective, Is KALV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.